Novel Therapeutic Agents May Reduce the Oncogenesis of Metastatic Prostate Cancer

Philadelphia, PA – Researchers have found that treating prostate cancer cells with novel cyclin-dependent kinase 19 (CDK19) and homologous cyclin-…

Novel Therapeutic Agents May Reduce the Oncogenesis of Metastatic Prostate Cancer

Leave a Reply

%d bloggers like this: